RespireRx Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc.verified

RSPI

Price:

$0.0018

Market Cap:

$657.75K

RespireRx Pharmaceuticals Inc. engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders. It has two drug platforms comprising ResolutionRx, a pharmaceutical cannabinoids platform, which includes dronabinol that acts upon the CB1 and CB2 endocannabinoid receptors for use in chemotherapy-induced nausea and vomiting, as well as for anorexia in patients with AIDS and obstructive sleep apnea; and EndeavourRx, a neuromodulators platform that comprises AMPAkines program, including proprietary compounds that are positive allosteric modulators (PAMs) of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-ty...[Read more]

Industry

Biotechnology

IPO Date

1989-11-06

Stock Exchange

OTC

Ticker

RSPI

The ROE as of December 2025 (TTM) for RespireRx Pharmaceuticals Inc. (RSPI) is 19.21%

According to RespireRx Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is 19.21%. This represents a change of 412.76% compared to the average of 3.75% of the last 4 quarters.

RespireRx Pharmaceuticals Inc. (RSPI) Historical ROE (quarterly & annually)

How has RSPI ROE performed in the past?

The mean historical ROE of RespireRx Pharmaceuticals Inc. over the last ten years is 82.21%. The current 19.21% ROE has changed -76.63% with respect to the historical average. Over the past ten years (40 quarters), RSPI's ROE was at its highest in in the September 2015 quarter at 107.81%. The ROE was at its lowest in in the June 2014 quarter at -2.83%.

Quarterly (TTM)
Annual

Average

82.21%

Median

52.66%

Minimum

17.70%

Maximum

208.30%

RespireRx Pharmaceuticals Inc. (RSPI) ROE by Quarter and Year

Discovering the peaks and valleys of RespireRx Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 328.96%

Maximum Annual ROE = 208.30%

Minimum Annual Increase = -88.67%

Minimum Annual ROE = 17.70%

Quarterly (TTM)
Annual
YearROEChange
202217.70%-54.23%
202138.67%-35.67%
202060.11%77.61%
201933.84%-25.13%
201845.21%-54.12%
201798.53%-41.36%
2016168.02%-19.34%
2015208.30%69.28%
2014123.05%328.96%
201328.69%-88.67%

RespireRx Pharmaceuticals Inc. (RSPI) Average ROE

How has RSPI ROE performed in the past?

The current ROE of RespireRx Pharmaceuticals Inc. (RSPI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

38.83%

5-year avg

39.11%

10-year avg

82.21%

RespireRx Pharmaceuticals Inc. (RSPI) ROE vs. Peers

How is RSPI’s ROE compared to its peers?

RespireRx Pharmaceuticals Inc.’s ROE is less than Viracta Therapeutics, Inc. (1.03%), greater than Innovation Pharmaceuticals Inc. (-93.60%), greater than THC Farmaceuticals, Inc. (-0.47%), greater than Bangi Inc. (-309.98%), less than Actavia Life Sciences, Inc. (243.82%), less than Biophytis S.A. (129.31%), less than Regen BioPharma, Inc. (17.33%), less than Comjoyful International Company (0.36%), greater than Biotron Limited (-63.03%), less than ChitogenX Inc. (13.28%),

Build a custom stock screener for RespireRx Pharmaceuticals Inc. (RSPI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RespireRx Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RespireRx Pharmaceuticals Inc. (RSPI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RespireRx Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is RespireRx Pharmaceuticals Inc.'s ROE?

How is the ROE calculated for RespireRx Pharmaceuticals Inc. (RSPI)?

What is the highest ROE for RespireRx Pharmaceuticals Inc. (RSPI)?

What is the 3-year average ROE for RespireRx Pharmaceuticals Inc. (RSPI)?

What is the 5-year average ROE for RespireRx Pharmaceuticals Inc. (RSPI)?

How does the current ROE for RespireRx Pharmaceuticals Inc. (RSPI) compare to its historical average?